Sou Hu Cai Jing·2025-07-29 07:51Core Viewpoint - The market shows mixed signals with a strong performance in specific sectors like pharmaceuticals and technology, while many individual stocks are declining, indicating a concentrated investment strategy among funds [1][3]. Pharmaceuticals Sector - The pharmaceutical sector saw a surge with several companies hitting the daily limit, driven by a significant deal between Heng Rui Medicine and GlaxoSmithKline worth $12.5 billion, marking the largest overseas contract for a Chinese pharmaceutical company [3]. - Policy support is evident as the National Medical Insurance Administration has clarified that "innovative drugs will not be included in centralized procurement," which opens up profit margins for pharmaceutical companies [3]. - The outflow of capital into the sector is notable, with over 5 billion net inflow in three days, indicating strong institutional interest [3][4]. Technology Sector - The technology sector, particularly the PCB (Printed Circuit Board) segment, is gaining traction, with companies like Fangbang and Woge Optical hitting the daily limit, and Shenghong Technology seeing a 17% increase, reaching a market cap of over 150 billion [3]. - The demand for high-end PCBs is surging due to Nvidia resuming supply and an explosion in the need for 800G optical modules, with orders extending to 2026 [3]. - The unveiling of Huawei's Ascend 384 super node at the World Artificial Intelligence Conference has further fueled interest in related stocks [3]. Infrastructure and Regional Development - The Yajiang Hydropower Station concept stocks are experiencing renewed interest, with companies like Tibet Tianlu and Xining Special Steel hitting the daily limit, driven by a surge in equipment orders as the project enters a critical construction phase [5]. - The regional scarcity of infrastructure stocks in Tibet benefits from policy incentives, such as tax breaks under the "Western Development" initiative [5]. Market Dynamics and Strategy - The trading volume today was 1.83 trillion, slightly up from the previous day, but to break through the 3610-point resistance, it needs to exceed 1.9 trillion [6]. - The upcoming Federal Reserve meeting could influence foreign capital inflow, depending on signals regarding interest rate cuts [6]. - A strategy of maintaining a 50% position in "hard logic" stocks (pharmaceuticals, PCBs, and Yajiang-related stocks) while avoiding speculative and cyclical stocks is recommended [7][8].